Literature DB >> 17420430

A predictive model of recurrent lower extremity cellulitis in a population-based cohort.

David R McNamara1, Imad M Tleyjeh, Elie F Berbari, Brian D Lahr, Jeffrey Martinez, Sultan A Mirzoyev, Larry M Baddour.   

Abstract

BACKGROUND: Cellulitis is common and recurs in some patients. The study described herein derived a predictive model for the recurrence of lower extremity cellulitis in a population-based cohort.
METHODS: We conducted a retrospective, population-based cohort study using the Rochester Epidemiology Project. We reviewed the medical records of Olmsted County, Minnesota, residents with lower extremity cellulitis occurring from January 1, 1999, to June 30, 2000. Univariate and multivariate Cox proportional hazards analyses were performed to evaluate risk factors in patients who experienced recurrent lower extremity cellulitis within 2 years. A predictive model was developed to estimate risk of recurrence based on a score of risk factors identified by multivariate analysis.
RESULTS: A total of 209 episodes met the definition of lower extremity cellulitis. Thirty-five patients (16.7%) experienced recurrence within 2 years. Multivariate analysis identified tibial area involvement, prior malignancy, and dermatitis affecting the ipsilateral limb as independent risk factors for recurrence, with hazard ratios of 5.02, 3.87, and 2.99 (P<.01), respectively. A score calculated from these variables (a count of 0, 1, 2, or 3) was developed to measure risk of recurrence. Based on the predictive model, the estimated probability of recurrence (95% confidence interval [CI]) within 2 years was 5.0% (95% CI, 1.6%-8.2%), 17.3% (95% CI, 11.1%-23.0%), 50.6% (95% CI, 34.2%-63.0%), or 92.8% (95% CI, 51.9%-98.9%) for a score of 0, 1, 2 or 3, respectively.
CONCLUSIONS: We derived a model including tibial area involvement, history of cancer, and dermatitis to predict recurrence of lower extremity cellulitis. Potential interventions can be incorporated into treatment to diminish the proclivity for recurrence in high-risk patients.

Entities:  

Mesh:

Year:  2007        PMID: 17420430     DOI: 10.1001/archinte.167.7.709

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment.

Authors:  Maciej Piotr Chlebicki; Choon Chiat Oh
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

2.  Over-admission and over-treatment of patients with cellulitis: a 5-year audit against international guidelines.

Authors:  Ailbhe Kiely; Sami Abd Elwahab; Declan McDonnell; Roisin Tully; Maria Randles; Mary Hickey; Felix Ofori-Kuma; Ivan Ivanovski; Suhail Khan; Karl Schmidt; Kenneth Mealy
Journal:  Ir J Med Sci       Date:  2019-08-14       Impact factor: 1.568

3.  Low-dose penicillin for recurrent cellulitis?

Authors:  Liz Nguyen; Kate Rowland
Journal:  J Fam Pract       Date:  2014-01       Impact factor: 0.493

4.  Clinical Study of an Online Tool for Standardizing Hospital Care.

Authors:  Mary J Burgess; Mark J Enzler; Deanne T Kashiwagi; Andi J Selby; M Rizwan Sohail; Paul R Daniels; Brian D Lahr; Farrell Lloyd; Larry D Baddour
Journal:  J Healthc Qual       Date:  2016 Nov/Dec       Impact factor: 1.095

5.  The Clinical Utility of Maceration Dressings in the Treatment of Inpatient Hand Infections: An Evaluation of Treatment Outcomes Compared to Standard Care.

Authors:  Ajith Malige; Vince Lands; Kristofer S Matullo
Journal:  Hand (N Y)       Date:  2019-06-05

6.  Treatment Duration and Associated Outcomes for Skin and Soft Tissue Infections in Patients With Obesity or Heart Failure.

Authors:  Claudia Ihm; Jesse D Sutton; Tristan T Timbrook; Emily S Spivak
Journal:  Open Forum Infect Dis       Date:  2019-05-07       Impact factor: 3.835

7.  Genetic susceptibility to non-necrotizing erysipelas/cellulitis.

Authors:  Katariina Hannula-Jouppi; Satu Massinen; Tuula Siljander; Siru Mäkelä; Katja Kivinen; Rasko Leinonen; Hong Jiao; Päivi Aitos; Matti Karppelin; Jaana Vuopio; Jaana Syrjänen; Juha Kere
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection.

Authors:  Yee Gyung Kwak; Seong Ho Choi; Tark Kim; Seong Yeon Park; Soo Hong Seo; Min Bom Kim; Sang Ho Choi
Journal:  Infect Chemother       Date:  2017-12

9.  Variability in Emergency Medicine Provider Decisions on Hospital Admission and Antibiotic Treatment in a Survey Study for Acute Bacterial Skin and Skin Structure Infections: Opportunities for Antimicrobial Stewardship Education.

Authors:  Safa S Almarzoky Abuhussain; Michelle A Burak; Danyel K Adams; Kelsey N Kohman; Serina B Tart; Athena L V Hobbs; Gabrielle Jacknin; Michael D Nailor; Katelyn R Keyloun; David P Nicolau; Joseph L Kuti
Journal:  Open Forum Infect Dis       Date:  2018-10-08       Impact factor: 3.835

10.  Daptomycin-Based 3 Week Treatment Scheme for the First Cellulitis Episode: Low Recurrence Rate Indicative of Decreased Recurrence Propensity?

Authors:  Ioannis D Bassukas; Ioannis Chaniotakis; Georgios Gaitanis
Journal:  Dermatol Ther (Heidelb)       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.